Tests

1st tests to order

gadolinium-enhanced MRI spine

Test
Result
Test

Imaging of choice for suspected MSCC.

MRI allows for assessment of the soft tissue structures, degree of cord compression, and details about leptomeningeal involvement. It is important that MRI of the whole spine is carried out, as multiple sites of metastasis are common. Post contrast fat-suppressed images allow differentiation of metastases from bone marrow.[7][19][41][42]​​[43][44][45]

Result

visualization of extradural tumor, extent of epidural disease, extent of cord compression, spinal cord edema; possible visualization of leptomeningeal and intramedullary tumors; visualization of tumor involvement/compression of spinal nerve roots, meninges, spinal musculature

MRI spine

Test
Result
Test

MRI without enhancement can often detect tumors, and should be used if the patient has a risk factor or contraindication for gadolinium use (e.g., allergy).[19][33]

Result

visualization of tumor, degree of cord compression, and soft tissue structures

CT myelography

Test
Result
Test

Should be used for diagnosis only in patients with contraindications for MRI (e.g., those with an implanted pacemaker or claustrophobia).

Myelography allows imaging of the degree of cord compression in flexion and extension.[7][19][33]

Result

visualization of compressed structures (classical hourglass constriction shape of the dye column)

Tests to consider

CT spine

Test
Result
Test

Can be useful for surgical or radiation therapy planning, including assessment of spinal stability, but should not be used for definitive diagnosis of MSCC.[7][19][33][41][42]​​

Result

bony infiltration or vertebral collapse from tumor, but not sensitive for detecting cord compression

x-ray

Test
Result
Test

Plain radiographs can be useful in the assessment for pathologic spinal fractures.[39] They can also help to determine whether spinal lesions are osteolytic, osteoblastic, or mixed. However, plain films should not be used to diagnose MSCC.[7]

Result

visualization of spinal fractures and skeletal metastases

bone scintigraphy

Test
Result
Test

Useful if primary imaging is not available, and in selected cases for staging purposes and planning of systemic treatment.

An osteotropic radioisotope (an agent that accumulates at the site of active bone production), most commonly technetium-99-labeled methylene diphosphonate (99mTc-MDP), is injected into the bloodstream.[49] Images are captured on film using a gamma camera.

Result

visualization of skeletal metastases; identifies areas of osteoblastic activity

positron emission tomography (PET)

Test
Result
Test

PET is superior to conventional bone scanning in terms of spatial resolution. 18F-Fluorodeoxyglucose is used to detect the presence of a tumor based on metabolic activity. PET may also be used as part of hybrid imaging techniques such as PET/CT and PET/MR.[41][49]

Result

identifies areas of osteoblastic activity or hypermetabolism

tumor biopsy and histopathology

Test
Result
Test

CT-guided biopsy and histopathology confirm the diagnosis of primary or metastatic spinal cord tumor.[7]

Genotyping of tumors has become a standard to aid in therapy and prognosis. The MSK-IMPACT data revealed crucial roles of the TP53, KRAS, PIK3CA, and BRAF genes in metastatic tumors. A whole-exome sequencing analysis of approximately 500 patients with metastatic tumors reported that TP53, CDKN2A, PTEN, PIK3CA, and RB1 were the most prevalent genes altered somatically in metastatic cancer.[25]

Result

tissue diagnosis of malignancy

serum calcium

Test
Result
Test

Hypercalcemia is the most common metabolic derangement seen in cancer patients.

Result

may be elevated in cancer patients

serum alkaline phosphatase

Test
Result
Test

Serum marker of bone turnover and mineralization, and a diagnostic marker for the presence of bone metastases. Elevated serum ALP is correlated with poor prognosis in the setting of bone metastasis.[50][51]

Result

may be elevated if bone metastases are present

cancer-specific laboratory testing

Test
Result
Test

Testing such as prostate specific antigen, breast cancer genes 1 and 2 (BRCA1 and 2), carcinoembryonic antigen, and serum and urine protein electrophoresis should be included based on clinical suspicion.[18]

Result

helps to identify primary tumor

cancer stem cell markers

Test
Result
Test

Cancer stem cells (a small subpopulation of cells within tumors capable of self-renewal, differentiation, and tumorigenicity) have been identified in solid tumors by a variety of markers, including CD133, ALDH, OCT3/4, SOX2, PROCR, CD24, CD29, CD44, and NESTIN.[52][53] Identifying markers helps to guide treatment, including predicting whether aggressive treatment is needed.

Result

positive for markers depending on tumor type

Use of this content is subject to our disclaimer